NPCE vs GUG
Comparison between NeuroPace Inc (NPCE, Company) and Guggenheim Active Allocation Fund (GUG, Company).
NPCE is from the Healthcare sector, while GUG is from the Financial Services sector.
5-Year PerformanceGUG has outperformed NPCE, delivering a return of +4.5% compared to -8.4%
NPCE vs GUG - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
NPCE vs GUG - Historical Returns
Returns include dividend reinvestment.
NPCE vs GUG - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | NPCE | GUG |
|---|---|---|
| 2026 | +3.10% | +9.72% |
| 2025 | +33.33% | +12.35% |
| 2024 | +14.42% | +11.59% |
| 2023 | +615.97% | +19.29% |
| 2022 | -85.70% | -26.97% |
| 2021 | -59.62% | -0.20% |
NPCE vs GUG Drawdown Comparison
The maximum drawdown for NPCE was -95.13%, occurring on Dec 28, 2022. This drawdown has not yet recovered.
The maximum drawdown for GUG was -32.74%, occurring on Sep 29, 2022. Recovery took 675 trading sessions.
The current NPCE drawdown is -40.98%. The current GUG drawdown is -0.67%.
| Rank | NPCE | GUG |
|---|---|---|
| #1 | -95.13% Apr 27, 2021 - Dec 28, 2022 | -32.74% Dec 21, 2021 - Aug 29, 2024 |
| #2 | N/A | -12.09% Sep 16, 2024 - Jun 24, 2025 |
| #3 | N/A | -7.80% Feb 13, 2026 - May 21, 2026 |
| #4 | N/A | -6.10% Oct 7, 2025 - Jan 13, 2026 |
| #5 | N/A | -4.08% May 28, 2026 - Jun 5, 2026 |
| #6 | N/A | -3.53% Sep 11, 2025 - Oct 7, 2025 |
| #7 | N/A | -2.62% Jun 25, 2025 - Aug 12, 2025 |
| #8 | N/A | -1.71% Jan 14, 2026 - Feb 5, 2026 |
| #9 | N/A | -1.05% Sep 4, 2025 - Sep 9, 2025 |
| #10 | N/A | -0.90% Aug 14, 2025 - Aug 22, 2025 |
| #11 | N/A | -0.90% Aug 30, 2024 - Sep 5, 2024 |
| #12 | N/A | -0.86% Feb 9, 2026 - Feb 13, 2026 |
| #13 | N/A | -0.74% Sep 9, 2025 - Sep 11, 2025 |
| #14 | N/A | -0.64% Aug 25, 2025 - Aug 28, 2025 |
| #15 | N/A | -0.20% Dec 8, 2021 - Dec 17, 2021 |
Correlation
Correlation between NPCE and GUG is 0.76 which considered as a strong positive correlation - the stocks tend to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks